U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07725601) titled 'VNS Algorithm for Advanced Dosing' on July 21.

Brief Summary: The goal of this clinical trial is to compare the standard programming of the VNS device (Control) to a modified programming (Augusta Way) in adults with epilepsy. The main question it aims to answer is:

Does the modified programming of the VNS reduce seizures faster than the standard programming?

Participants in both groups will:

1. Attend up to 3 study visits every 3 months for 2 years

2. Answer questionnaires to assess quality of life and cognitive function

3. Maintain a diary of seizure activity

Study Start Date: Aug. 01, 2025

Study Type: INTERVENTIONAL

Condit...